675 related articles for article (PubMed ID: 30049445)
1. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.
Gan T; Liao B; Xu G
J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445
[TBL] [Abstract][Full Text] [Related]
2. Glycated albumin in diabetic patients with chronic kidney disease.
Zheng CM; Ma WY; Wu CC; Lu KC
Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
[TBL] [Abstract][Full Text] [Related]
3. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
[TBL] [Abstract][Full Text] [Related]
4. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
[TBL] [Abstract][Full Text] [Related]
5. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
Sany D; Elshahawy Y; Anwar W
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
[TBL] [Abstract][Full Text] [Related]
6. Determination of serum glycated albumin and high sensitivity C - reactive protein in the insight of cardiovascular complications in diabetic chronic kidney disease patients.
Vijayaraghavan B; Padmanabhan G; Ramanathan K
Afr Health Sci; 2020 Mar; 20(1):308-313. PubMed ID: 33402919
[TBL] [Abstract][Full Text] [Related]
7. How does CKD affect HbA1c?
Bloomgarden Z; Handelsman Y
J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of glycated albumin as another glycemic control marker.
Koga M; Kasayama S
Endocr J; 2010; 57(9):751-62. PubMed ID: 20724796
[TBL] [Abstract][Full Text] [Related]
9. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
10. [Insights on glycated albumin].
Hay-Lombardie A; Kamel S; Bigot-Corbel E
Ann Biol Clin (Paris); 2019 Aug; 77(4):407-414. PubMed ID: 31418702
[TBL] [Abstract][Full Text] [Related]
11. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
Sato A
Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
[TBL] [Abstract][Full Text] [Related]
12. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
Jung M; Warren B; Grams M; Kwong YD; Shafi T; Coresh J; Rebholz CM; Selvin E
J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090
[TBL] [Abstract][Full Text] [Related]
13. Glycated albumin and the risk of chronic kidney disease in subjects with Type 2 Diabetes: A study in North Indian Population.
Raghav A; Ahmad J; Noor S; Alam K; Mishra BK
Diabetes Metab Syndr; 2018 May; 12(3):381-385. PubMed ID: 29396252
[TBL] [Abstract][Full Text] [Related]
14. Variability in glycated albumin levels predicts the progression of diabetic nephropathy.
Park SB; Kim SS; Kim IJ; Nam YJ; Ahn KH; Kim JH; Jeon YK; Kim BH; Song SH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2017 Jun; 31(6):1041-1046. PubMed ID: 28396158
[TBL] [Abstract][Full Text] [Related]
15. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
Wang N; Xu Z; Han P; Li T
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the accuracy of glycemic markers and the chronic kidney disease stage in patients with type 2 diabetes mellitus.
Harada K; Sumida K; Yamaguchi Y; Akai Y
Clin Nephrol; 2014 Aug; 82(2):107-14. PubMed ID: 24985951
[TBL] [Abstract][Full Text] [Related]
17. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
[TBL] [Abstract][Full Text] [Related]
18. Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease.
Okada T; Nakao T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T
Intern Med; 2011; 50(1):23-9. PubMed ID: 21212569
[TBL] [Abstract][Full Text] [Related]
19. A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in Taiwan.
Hsu P; Ai M; Kanda E; Yu NC; Chen HL; Chen HW; Cheng MH; Kohzuma T; Schaefer EJ; Yoshida M
Atherosclerosis; 2015 Sep; 242(1):327-33. PubMed ID: 26247684
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.
Yazdanpanah S; Rabiee M; Tahriri M; Abdolrahim M; Rajab A; Jazayeri HE; Tayebi L
Crit Rev Clin Lab Sci; 2017 Jun; 54(4):219-232. PubMed ID: 28393586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
